 David Wagner
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD40 Antigens | 22 | 2026 | 90 | 7.290 |
Why?
| | CD40 Ligand | 9 | 2023 | 40 | 1.670 |
Why?
| | Diabetes Mellitus, Type 1 | 15 | 2026 | 3906 | 1.660 |
Why?
| | CD4-Positive T-Lymphocytes | 10 | 2024 | 1130 | 1.600 |
Why?
| | Peptides | 4 | 2026 | 999 | 1.500 |
Why?
| | T-Lymphocyte Subsets | 5 | 2019 | 415 | 1.290 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 2 | 2019 | 66 | 1.050 |
Why?
| | Multiple Sclerosis | 3 | 2022 | 484 | 1.030 |
Why?
| | Mice, Inbred NOD | 14 | 2019 | 610 | 1.000 |
Why?
| | Autoimmunity | 8 | 2014 | 935 | 0.920 |
Why?
| | Dog Diseases | 1 | 2026 | 70 | 0.890 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2017 | 131 | 0.890 |
Why?
| | Autoimmune Diseases | 3 | 2024 | 464 | 0.780 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2022 | 28 | 0.740 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2022 | 82 | 0.700 |
Why?
| | Diabetes Mellitus | 2 | 2026 | 1098 | 0.650 |
Why?
| | T-Lymphocytes | 5 | 2013 | 1984 | 0.650 |
Why?
| | Forkhead Transcription Factors | 2 | 2013 | 202 | 0.620 |
Why?
| | Inflammation | 3 | 2026 | 2881 | 0.590 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2017 | 331 | 0.590 |
Why?
| | Therapies, Investigational | 1 | 2018 | 18 | 0.560 |
Why?
| | Oligopeptides | 1 | 2019 | 269 | 0.510 |
Why?
| | Signal Transduction | 8 | 2023 | 5239 | 0.500 |
Why?
| | Mice | 20 | 2024 | 18394 | 0.490 |
Why?
| | Demyelinating Diseases | 1 | 2017 | 85 | 0.480 |
Why?
| | Cell Movement | 3 | 2017 | 965 | 0.480 |
Why?
| | Animals | 24 | 2026 | 38177 | 0.460 |
Why?
| | Central Nervous System | 1 | 2017 | 281 | 0.420 |
Why?
| | Dogs | 2 | 2026 | 439 | 0.400 |
Why?
| | Flow Cytometry | 7 | 2017 | 1173 | 0.390 |
Why?
| | Cytokines | 4 | 2017 | 2066 | 0.390 |
Why?
| | fas Receptor | 1 | 2013 | 92 | 0.390 |
Why?
| | Galectins | 1 | 2012 | 27 | 0.360 |
Why?
| | CTLA-4 Antigen | 2 | 2012 | 104 | 0.360 |
Why?
| | Membrane Microdomains | 2 | 2010 | 34 | 0.360 |
Why?
| | Biomedical Research | 1 | 2018 | 713 | 0.350 |
Why?
| | DNA-Binding Proteins | 2 | 2013 | 1503 | 0.350 |
Why?
| | Autoantigens | 2 | 2012 | 429 | 0.340 |
Why?
| | Mice, Inbred BALB C | 6 | 2023 | 1253 | 0.330 |
Why?
| | Islets of Langerhans | 1 | 2017 | 841 | 0.330 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 81 | 0.320 |
Why?
| | Epitopes | 1 | 2012 | 485 | 0.310 |
Why?
| | CD4 Antigens | 2 | 2008 | 139 | 0.310 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2010 | 163 | 0.310 |
Why?
| | Homeodomain Proteins | 1 | 2013 | 530 | 0.300 |
Why?
| | Cell Proliferation | 5 | 2017 | 2506 | 0.290 |
Why?
| | Adoptive Transfer | 3 | 2017 | 198 | 0.290 |
Why?
| | Immune Tolerance | 2 | 2012 | 379 | 0.280 |
Why?
| | TNF Receptor-Associated Factor 2 | 1 | 2008 | 8 | 0.280 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2008 | 389 | 0.280 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 80 | 0.270 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2013 | 668 | 0.260 |
Why?
| | Platelet Membrane Glycoprotein IIb | 1 | 2007 | 5 | 0.260 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2006 | 16 | 0.250 |
Why?
| | Interferon-gamma | 3 | 2017 | 784 | 0.250 |
Why?
| | Biomarkers | 3 | 2024 | 4284 | 0.220 |
Why?
| | Spleen | 3 | 2017 | 508 | 0.210 |
Why?
| | Hospitals, Animal | 1 | 2024 | 2 | 0.210 |
Why?
| | Hospitals, Teaching | 1 | 2024 | 119 | 0.200 |
Why?
| | Trypanosoma cruzi | 1 | 2023 | 39 | 0.200 |
Why?
| | Genes, RAG-1 | 1 | 2003 | 12 | 0.200 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2023 | 27 | 0.190 |
Why?
| | Chagas Disease | 1 | 2023 | 42 | 0.190 |
Why?
| | Integrins | 1 | 2023 | 90 | 0.180 |
Why?
| | Blotting, Western | 2 | 2017 | 1187 | 0.180 |
Why?
| | Immunomodulation | 2 | 2012 | 101 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 573 | 0.170 |
Why?
| | Mice, SCID | 2 | 2017 | 369 | 0.160 |
Why?
| | Mice, Inbred C57BL | 5 | 2019 | 6007 | 0.160 |
Why?
| | Female | 11 | 2026 | 78605 | 0.150 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2609 | 0.150 |
Why?
| | Lymphocyte Activation | 2 | 2017 | 1127 | 0.150 |
Why?
| | CD28 Antigens | 2 | 2017 | 58 | 0.150 |
Why?
| | Amino Acids | 1 | 2023 | 522 | 0.140 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 194 | 0.140 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 247 | 0.140 |
Why?
| | Mice, Knockout | 2 | 2017 | 3127 | 0.140 |
Why?
| | Phenotype | 2 | 2017 | 3172 | 0.130 |
Why?
| | Freund's Adjuvant | 1 | 2017 | 18 | 0.130 |
Why?
| | Cell Survival | 2 | 2012 | 1099 | 0.130 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 783 | 0.130 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2017 | 53 | 0.130 |
Why?
| | Immunologic Memory | 1 | 2019 | 366 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2022 | 991 | 0.120 |
Why?
| | Cell Separation | 2 | 2014 | 307 | 0.120 |
Why?
| | Cell Division | 2 | 2008 | 766 | 0.110 |
Why?
| | Lymph Nodes | 1 | 2017 | 502 | 0.110 |
Why?
| | Spinal Cord | 1 | 2017 | 383 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2017 | 4580 | 0.100 |
Why?
| | Precision Medicine | 1 | 2018 | 460 | 0.100 |
Why?
| | Ku Autoantigen | 1 | 2013 | 12 | 0.100 |
Why?
| | Antigens, Nuclear | 1 | 2013 | 16 | 0.100 |
Why?
| | Humans | 10 | 2024 | 145305 | 0.100 |
Why?
| | Thymocytes | 1 | 2013 | 34 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1063 | 0.100 |
Why?
| | HLA-DR Antigens | 1 | 2014 | 220 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2017 | 699 | 0.100 |
Why?
| | Interleukin-17 | 1 | 2013 | 118 | 0.090 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2012 | 29 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2012 | 2192 | 0.090 |
Why?
| | Haplotypes | 1 | 2014 | 490 | 0.090 |
Why?
| | Receptors, Virus | 1 | 2012 | 96 | 0.090 |
Why?
| | Protein Transport | 1 | 2013 | 441 | 0.090 |
Why?
| | NF-kappa B | 2 | 2008 | 662 | 0.090 |
Why?
| | Leukocyte Common Antigens | 1 | 2011 | 90 | 0.090 |
Why?
| | Disease Progression | 2 | 2017 | 2855 | 0.080 |
Why?
| | RNA, Messenger | 2 | 2013 | 2833 | 0.080 |
Why?
| | Interleukin-2 | 1 | 2012 | 437 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2026 | 11731 | 0.080 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2014 | 342 | 0.080 |
Why?
| | Brain Ischemia | 1 | 2014 | 358 | 0.080 |
Why?
| | Benzimidazoles | 1 | 2011 | 190 | 0.080 |
Why?
| | Cell Nucleus | 1 | 2013 | 620 | 0.080 |
Why?
| | Prediabetic State | 1 | 2013 | 246 | 0.080 |
Why?
| | Heart Arrest | 1 | 2014 | 407 | 0.080 |
Why?
| | Molecular Weight | 1 | 2010 | 327 | 0.080 |
Why?
| | Glycosylation | 1 | 2010 | 172 | 0.080 |
Why?
| | Down-Regulation | 1 | 2012 | 627 | 0.070 |
Why?
| | Bleomycin | 1 | 2011 | 253 | 0.070 |
Why?
| | DNA Primers | 1 | 2010 | 512 | 0.070 |
Why?
| | Protein Isoforms | 1 | 2010 | 402 | 0.070 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2008 | 19 | 0.070 |
Why?
| | Male | 5 | 2026 | 72628 | 0.070 |
Why?
| | bcl-X Protein | 1 | 2008 | 45 | 0.070 |
Why?
| | Magnetics | 1 | 2008 | 48 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2007 | 47 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2012 | 4155 | 0.060 |
Why?
| | Protein Binding | 1 | 2013 | 2283 | 0.060 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 395 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2006 | 2053 | 0.060 |
Why?
| | Base Sequence | 1 | 2010 | 2191 | 0.060 |
Why?
| | Cell Death | 1 | 2008 | 383 | 0.060 |
Why?
| | Time Factors | 1 | 2017 | 7186 | 0.060 |
Why?
| | HLA Antigens | 1 | 2007 | 232 | 0.060 |
Why?
| | HIV Infections | 1 | 2021 | 3158 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 555 | 0.060 |
Why?
| | Adolescent | 3 | 2021 | 22507 | 0.050 |
Why?
| | Brain | 1 | 2017 | 2945 | 0.050 |
Why?
| | Homeostasis | 1 | 2008 | 641 | 0.050 |
Why?
| | Genes, T-Cell Receptor alpha | 1 | 2003 | 11 | 0.050 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2003 | 23 | 0.050 |
Why?
| | Mice, Inbred C3H | 1 | 2023 | 251 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2158 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2931 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 277 | 0.050 |
Why?
| | Clone Cells | 1 | 2003 | 266 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2007 | 2033 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2003 | 541 | 0.040 |
Why?
| | Young Adult | 2 | 2021 | 14163 | 0.040 |
Why?
| | Pancreas | 1 | 2004 | 342 | 0.040 |
Why?
| | Th1 Cells | 1 | 2002 | 139 | 0.040 |
Why?
| | North Carolina | 1 | 2021 | 128 | 0.040 |
Why?
| | Thymus Gland | 1 | 2002 | 311 | 0.040 |
Why?
| | Adult | 3 | 2021 | 40627 | 0.040 |
Why?
| | Homosexuality, Male | 1 | 2021 | 223 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2007 | 3613 | 0.040 |
Why?
| | Middle Aged | 2 | 2014 | 36021 | 0.040 |
Why?
| | Universities | 1 | 2021 | 453 | 0.030 |
Why?
| | Lung | 1 | 2011 | 4112 | 0.030 |
Why?
| | Students | 1 | 2021 | 663 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2008 | 2464 | 0.030 |
Why?
| | Aged | 1 | 2014 | 26001 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2014 | 322 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1420 | 0.020 |
Why?
| | Cytological Techniques | 1 | 2011 | 28 | 0.020 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2011 | 197 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5883 | 0.020 |
Why?
| | Hippocampus | 1 | 2014 | 967 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 6079 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1054 | 0.020 |
Why?
| | Lung Injury | 1 | 2011 | 239 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2008 | 310 | 0.010 |
Why?
| | Up-Regulation | 1 | 2008 | 852 | 0.010 |
Why?
| | Models, Statistical | 1 | 2008 | 682 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2882 | 0.010 |
Why?
| | Software | 1 | 2008 | 692 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1525 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2011 | 1980 | 0.010 |
Why?
| | Cohort Studies | 1 | 2008 | 5982 | 0.010 |
Why?
|
|
Wagner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|